Similarity Between the Sequences of Taxol-Selected Peptides and the Disordered Loop of the Anti-Apoptotic Protein, BCL-2
暂无分享,去创建一个
[1] W. May,et al. Bcl-2 Phosphorylation Required for Anti-apoptosis Function* , 1997, The Journal of Biological Chemistry.
[2] John Calvin Reed,et al. Somatic point mutations in the translocated bcl-2 genes of non-Hodgkin's lymphomas and lymphocytic leukemias: implications for mechanisms of tumor progression. , 1993, Leukemia & lymphoma.
[3] M. Swindells,et al. Protein clefts in molecular recognition and function. , 1996, Protein science : a publication of the Protein Society.
[4] R. W. Janes,et al. Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein. , 1999, Journal of molecular biology.
[5] R. Meadows,et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death , 1996, Nature.
[6] C. Croce,et al. Bcl2 is the guardian of microtubule integrity. , 1997, Cancer research.
[7] S. Henikoff,et al. Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Jordan,et al. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. S. Spolar,et al. Coupling of local folding to site-specific binding of proteins to DNA. , 1994, Science.
[10] C. Lieu,et al. Dual cytotoxic mechanisms of submicromolar taxol on human leukemia HL-60 cells. , 1997, Biochemical pharmacology.
[11] N. Kunishima,et al. Crystal Structure of Rat Bcl-xL , 1997, The Journal of Biological Chemistry.
[12] C. Croce,et al. Inactivation of Bcl-2 by phosphorylation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[13] S. Kaufmann,et al. Apoptosis : pharmacological implications and therapeutic opportunities , 1997 .
[14] R. Craig. The bcl-2 gene family. , 1995, Seminars in cancer biology.
[15] John McCafferty,et al. Phage display of peptides and proteins : a laboratory manual , 1996 .
[16] P. Schiff,et al. Promotion of microtubule assembly in vitro by taxol , 1979, Nature.
[17] S. Fesik,et al. Identification of a novel regulatory domain in Bcl‐xL and Bcl‐2 , 1997, The EMBO journal.
[18] "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. , 1998, Cancer research.
[19] Folding and binding. From theory to therapy. , 1997, Current opinion in structural biology.
[20] C. Croce,et al. Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. , 1998, Cancer research.
[21] A. Dunker. The pacific symposium on biocomputing , 1998 .
[22] A.K. Dunker,et al. Identifying disordered regions in proteins from amino acid sequence , 1997, Proceedings of International Conference on Neural Networks (ICNN'97).
[23] Kenneth H. Downing,et al. Structure of the αβ tubulin dimer by electron crystallography , 1998, Nature.
[24] L. Peters,et al. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. , 1996, Journal of the National Cancer Institute.
[25] A. Wlodawer,et al. The structural basis of phage display elucidated by the crystal structure of the N-terminal domains of g3p , 1998, Nature Structural Biology.
[26] A K Dunker,et al. Protein disorder and the evolution of molecular recognition: theory, predictions and observations. , 1998, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.
[27] Dill,et al. Folding and binding. , 1996, Current opinion in structural biology.
[28] J. Dichgans,et al. Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest. , 1998, British Journal of Cancer.